하지불안증후군에서 인지기능에 대한 프라미펙솔의 효과

참고문헌 (38)

1. Fulda S, "Short-term attention and verbal fluency is decreased in restless legs syndrome patients", Mov Disord, 25, pp.2641~2648 (2010)
2. Gamaldo CE, "A further evaluation of the cognitive deficits associated with restless legs syndrome (RLS)", Sleep Med, 9, pp.500~505 (2008)
3. Celle S, "Prevalence and clinical correlates of restless legs syndrome in an elderly French population: the synapse study", J Gerontol A Biol Sci Med Sci, 65, pp.167~173 (2010)
4. Pearson VE, "Cognitive deficits associated with restless legs syndrome (RLS)", Sleep Med, 7, pp.25~30 (2006)
5. Jung KY, "Electrophysiologic disturbances during daytime in patients with restless legs syndrome: further evidence of cognitive dysfunction?", Sleep Med, 12, pp.416~421 (2011)
6. Hornyak M, "Efficacy and safety of dopamine agonists in restless legs syndrome", Sleep Med, 13, pp.228~236 (2012)
7. Ferini-Strambi L, "Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial", Sleep Med, 9, pp.874~881 (2008)
8. Kallweit U, "Dopaminergic treatment in idiopathic restless legs syndrome: effects on subjective sleepiness", Clin Neuropharmacol, 33, pp.276~278 (2010)
9. Manconi M, "Pramipexole versus ropinirole:polysomnographic acute effects in restless legs syndrome", Mov Disord, 26, pp.892~895 (2011)
10. 조용원, "The Effect of Ropinirole on the Quality of Life in Patients with Restless Legs Syndrome in Korea: An 8-Week, Multicenter, Prospective Study", Journal of Clinical Neurology, 9(1), pp.51~56 (2013), 대한신경과학회[DOI]
11. Walters AS, "Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group", Mov Disord, 10, pp.634~642 (1995)
12. Roth T, "A new questionnaire to detect sleep disorders", Sleep Med, 3, pp.99~108 (2002)
13. Buysse DJ, "The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research", Psychiatry Res, 28, pp.193~213 (1989)
14. Johns MW, "A new method for measuring daytime sleepiness: the Epworth sleepiness scale", Sleep, 14, pp.540~545 (1991)
15. Bastien CH, "Validation of the Insomnia Severity Index as an outcome measure for insomnia research", Sleep Med, 2, pp.297~307 (2001)
16. Arnau RC, "Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients", Health Psychol, 20, pp.112~119 (2001)
17. Walters AS, "Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome", Sleep Med, 4, pp.121~132 (2003)
18. Kang Y, "Parallel short forms for the Korean-Boston Naming Test (K-BNT)", J Korean Neurol Assoc, 18, pp.144~150 (2000)
19. Deckersbach T, "Reliability and validity of a scoring system for measuring organizational approach in the Complex Figure Test", J Clin Exp Neuropsychol, 22, pp.640~648 (2000)
20. Kim JK, "Normative study of the Korean-California Verbal Learning Test (K-CVLT)", Clin Neuropsychol, 13, pp.365~369 (1999)
21. Ross TP, "The reliability and validity of qualitative scores for the Controlled Oral Word Association Test", Arch Clin Neuropsychol, 22, pp.475~488 (2007)
22. Joy S, "Speed and memory in the WAIS-III Digit Symbol--Coding subtest across the adult lifespan", Arch Clin Neuropsychol, 19, pp.759~767 (2004)
23. Tombaugh TN, "Trail Making Test A and B: normative data stratified by age and education", Arch Clin Neuropsychol, 19, pp.203~214 (2004)
24. Kim TY, "Development of the Korean Stroop Test and Study of the Validity and the Reliability", J Korean Geriatr Soc, 8, pp.233~240 (2004)
25. Benes H, "Ropinirole improves depressive symptoms and restless legs syndrome severity in RLS patients: a multicentre, randomized, placebo-controlled study", J Neurol, 258, pp.1046~1054 (2011)
26. Montagna P, "Randomized trial of pramipexole for patients with restless legs syndrome (RLS) and RLS-related impairment of mood", Sleep Med, 12, pp.34~40 (2011)
27. Fulda S, "Further evidence for executive dysfunction in subjects with RLS from a non-clinical sample", Sleep Med, 12, pp.1003~1007 (2011)
28. Connor JR, "Postmortem and imaging based analyses reveal CNS decreased myelination in restless legs syndrome", Sleep Med, 12, pp.614~619 (2011)
29. Astrakas LG, "T2 relaxometry and fMRI of the brain in late-onset restless legs syndrome", Neurology, 71, pp.911~916 (2008)
30. Allen R, "Dopamine and iron in the pathophysiology of restless legs syndrome (RLS)", Sleep Med, 5, pp.385~391 (2004)
31. Nieoullon A, "Dopamine and the regulation of cognition and attention", Prog Neurobiol, 67, pp.53~83 (2002)
32. Cools R, "Enhanced or impaired cognitive function in Parkinson’s disease as a function of dopaminergic medication and task demands", Cereb Cortex, 11, pp.1136~1143 (2001)
33. Kimberg DY, "Effects of bromocriptine on human subjects depend on working memory capacity", Neuroreport, 8, pp.3581~3585 (1997)
34. Cools R, "Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson’s disease", Neurosci Biobehav Rev, 30, pp.1~23 (2006)
35. Hazy TE, "Banishing the homunculus: making working memory work", Neuroscience, 139, pp.105~118 (2006)
36. Costa A, "Dopaminergic modulation of visual-spatial working memory in Parkinson’s disease", Dement Geriatr Cogn Disord, 15, pp.55~66 (2003)
37. Cools R, "Inverted-U-shaped dopamine actions on human working memory and cognitive control", Biol Psychiatry, 69, pp.e113~e125 (2011)
38. Floresco SB, "Prefrontal dopamine and behavioral flexibility: shifting from an “inverted-U” toward a family of functions", Front Neurosci, 7, pp.62~ (2013)

관련 논문AI추천